
Zoltan Oltvai
Oltvai Lab · University of Rochester Medicine
Credentials: · · ·
History
1989–1990- 1988–1989

- 1980–1984
| Semmelweis University (Hungary).
Research
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
Cell · 1993 · First of 3 authors · 5,650 citations
Network biology: understanding the cell's functional organization
Review · Nature Reviews Genetics · 2004 · 4,566 citations
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Cell · 1993 · 3,206 citations

7 papers
- CB
5 papers

5 papers

4 papers · 1 as a fellow
- DN
4 papers · 4 as a fellow
- AN
2 papers

2 papers

2 papers
Grants
- 2006–2011
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $3M · University of Pittsburgh at Pittsburgh
- 2004–2007
High Performance Computing for Biomedical Research
National Center for Research Resources · P41
Project lead · $2K · Carnegie-Mellon University
- 2002–2007
System-Level Properties of the E. coli Metabolic Network
National Institute of Allergy and Infectious Diseases · K02
Contact PI · $473.1K · University of Pittsburgh at Pittsburgh
- 1997–2003
Mechanism & Regulation of Bcl-2 Antiproliferative Effect
National Cancer Institute · R29
Contact PI · $518K · Northwestern University

